Understanding Your Laboratory Test: A Patient Guide to Medical Testing
This test measures the amount of 3,4-Dihydroxyphenylacetate, a dopamine breakdown product, in your urine collected over 24 hours.
{"DHPAC is a substance produced when your body breaks down dopamine","This test helps detect tumors that produce abnormal amounts of dopamine","A 24-hour urine collection is required for accurate results","Elevated levels may indicate neuroblastoma or other tumors","The test is mainly used for cancer diagnosis and monitoring"}
Key facts at a glance
- LOINC
- 53548-4
- Short code
- DHPAC24
- Synonyms
- 3,4-DiOH-phenylacetate 24h Ur-sRate
- Category
- chemistry
- Sample
- urine
- Container
- 24-hour urine collection container with appropriate preservative (typically hydrochloric acid or acetic acid)
- Units
- N/A
- Ref low
- 0
- Ref high
- 35
- Critical range
- — – 100 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- High Performance Liquid Chromatography (HPLC) with Electrochemical Detection
- CPT
- 82540
- SNOMED
- 271561001
- Specimen volume
- Complete 24-hour collection; minimum 10 mL aliquot for analysis
- Stability
- Refrigerate during collection. Stable at 2-8°C for up to 7 days. For longer storage, freeze at -20°C or below. Protect from light.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 48–168 hours
- Order
- routine
This test is a laboratory procedure that helps your doctor evaluate your overall health. It usually involves analyzing a sample of your blood, urine, or other body tissue to gather important information about how your body is functioning.
The 3,4-Dihydroxyphenylacetate (DHPAC) test measures how much of this substance is in your urine. DHPAC is a byproduct that remains when your body breaks down dopamine, a hormone and chemical messenger in your brain. Normally, your body produces small amounts of DHPAC. However, certain tumors can cause your body to make too much dopamine, which then breaks down into elevated levels of DHPAC.
This test is performed to help diagnose a medical condition, monitor an ongoing illness, or screen for potential health problems before symptoms appear. Your healthcare provider may also order it to check how well a current treatment is working for you.
This test is primarily used to help diagnose and monitor conditions including: Neuroblastoma (a type of cancer that develops from nerve cells, often in children), Pheochromocytoma (a tumor of the adrenal gland), and other rare tumors that affect dopamine production. Your doctor may also order this test if you have symptoms such as abdominal pain, weight loss, or high blood pressure that might be related to these conditions.
The test is typically done at a clinic, hospital, or laboratory. A trained technician will collect the required sample, often by drawing a small amount of blood from a vein in your arm, and send it to the lab for analysis. The procedure is quick and causes only minor discomfort.
This test requires a 24-hour urine collection. You will receive a special container from the laboratory. On the day of collection, start by urinating into the toilet when you wake up. For the next 24 hours, collect all your urine in the provided container. Keep the container refrigerated or in a cool place. At the end of 24 hours, urinate one final time and add that sample to the container. Return the container to the lab as instructed.
Your results will show whether your values fall within the normal reference range. Abnormal results do not always mean you have a serious condition, so your doctor will review them with you, explain what they indicate, and discuss any follow-up testing or treatment that may be needed.
Your doctor will interpret your results based on your age, medical history, and other factors. Higher than normal DHPAC levels may suggest the presence of a tumor that produces dopamine. Normal or low levels generally indicate no evidence of dopamine-producing tumors. Your doctor will discuss your specific results with you and determine if any further testing or treatment is needed.
Reference range
Reference range: 0.0-35.0 micromoles per 24 hours (umol/24h). Values may vary by laboratory methodology and patient population.N/A
Patient should avoid foods high in catecholamines (bananas, vanilla, chocolate, coffee, tea) for 48 hours before and during collection. Avoid aspirin, vitamin B supplements, and certain medications (levodopa, methyldopa, monoamine oxidase inhibitors) for 48 hours before collection unless specifically instructed by physician. Collect urine in container with preservative provided by laboratory. Record start time of collection.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
DHPAC measurement is primarily used as a tumor marker for neuroblastoma, the most common extracranial solid cancer in children. It helps in initial diagnosis, assessing tumor burden, and monitoring treatment response. Serial measurements during treatment can indicate whether therapy is effective. The test may also be used in screening individuals with family history of relevant cancers or genetic conditions that increase tumor risk.
Frequently asked questions
Do I need to fast before this test?
Is this test only for children?
How long does it take to get results?
Does an abnormal result mean I have cancer?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy